(Q35991941)

11 August 2017

1 reference

title

Infectious risks associated with the transfusion of blood components and pathogen inactivation in Japan (English)

1 reference

11 August 2017

1 reference

Masahiro Satake

1

1 reference

11 August 2017

publication date

1 November 2004

1 reference

International Journal of Hematology

11 August 2017

published in

1 reference

11 August 2017

volume

80

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

306-310

1 reference

Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets

11 August 2017

cites work

1 reference

12 December 2020

Nucleic acid amplification testing of hepatitis B virus

1 reference

12 December 2020

Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease

1 reference

12 December 2020

Prevention of transfusion-associated graft-versus-host disease by photochemical treatment

1 reference

12 December 2020

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

12 December 2020

Residual risk of transfusion-transmitted diseases in Japan and pathogen inactivation

1 reference

12 December 2020

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

1 reference

12 December 2020

West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivation

1 reference

12 December 2020

Pathogen inactivation in cellular blood components: clinical trials and implications of introduction to transfusion medicine.

1 reference

12 December 2020

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan

1 reference

12 December 2020

Results of viral marker screening of unpaid blood donations and probability of window period donations in 1997. EPFA Working Group on Quality Assurance

1 reference

12 December 2020

Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository

1 reference

12 December 2020

Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate.

1 reference

12 December 2020

West Nile virus in plasma is highly sensitive to methylene blue-light treatment

1 reference

12 December 2020

The future use of pathogen-inactivated platelet concentrates

1 reference

12 December 2020

Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan.

1 reference

12 December 2020

Identifiers

DOI

10.1532/IJH97.04118

1 reference

Dimensions Publication ID

11 August 2017

1021733987

0 references

1 reference